Company intelligence / Profile preview
MediWound
Yavne, Israelmediwound.com ↗
- Ownership
- Public · MDWD
- Employees
- ~111
- Development stage
- Commercial
01
Overview
NexoBrid has demonstrated significant reduction in surgical interventions required for burn eschar removal with proven safety and efficacy across multiple global studies. EscharEx has met primary endpoints in several Phase II trials showing rapid debridement of chronic wounds with a strong safety profile. MW005 showed complete clinical/histological clearance of BCC lesions in early trials[1][4][9].
- Therapeutic areas
- OncologyDermatology
- Modalities
- Enzymatic biologics (proteolytic enzyme-based therapeutics)Topical biological drugs
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
Vericel Corporation – U.S. commercialization partner for NexoBrid[2]Kaken Pharmaceutical – Japan commercialization partner[2]Biological E/Biological E Limited or BSV – India commercialization partner[2]Solventum & Mölnlycke & MIMEDX – R&D partners on EscharEx clinical development [2][4]
04
Financials
- Market cap
- $177.8M
- Total revenue
- $3.1M
- Enterprise value
- $152M
Beyond the preview
Go deeper on MediWound.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MediWound.